Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Mihály, Makara"'
Autor:
Klára Werling, Béla Hunyady, Mihály Makara, Krisztina Nemesi, Gábor Horváth, Ferenc Schneider, Judit Enyedi, Zsófia Müller, Miklós Lesch, Zoltán Péterfi, Tamás Tóth, Judit Gács, Zsuzsanna Fehér, Eszter Ujhelyi, Emese Molnár, Anna Nemes Nagy
Publikováno v:
Viruses, Vol 14, Iss 2, p 308 (2022)
A hepatitis C virus (HCV) screening and treatment program was conducted in Hungarian prisons on a voluntary basis. After HCV-RNA testing and genotyping for anti-HCV positives, treatments with direct-acting antiviral agents were commenced by hepatolog
Externí odkaz:
https://doaj.org/article/458fe4f14d1943199fe10b3f4033986b
Autor:
Mihály Sulyok, Tamás Ferenci, Mihály Makara, Gábor Horváth, János Szlávik, Zsófia Rupnik, Luca Kormos, Zsuzsanna Gerlei, Zita Sulyok, István Vályi-Nagy
Publikováno v:
PeerJ, Vol 5, p e2867 (2017)
Background Liver disease has become an important cause of morbidity and mortality even in those HIV-infected individuals who are devoid of hepatitis virus co-infection. The aim of this study was to evaluate the degree of hepatic fibrosis and the role
Externí odkaz:
https://doaj.org/article/9bd7ffbcafc248299fdbf7134cb1ea82
Autor:
Ferenc Schneider, István Tornai, Judit Gervain, László Rókusz, Klára Werling, Gabriella Lengyel, Mihály Makara, Ferenc Szalay, Zsuzsanna Gerlei, Gabriella Pár, András Kiss, János Schuller, Alajos Pár, Zoltán Péter, Gábor V. Horváth, Béla Hunyady
Publikováno v:
Central European Journal of Gastroenterology and Hepatology. 7:7-21
Publikováno v:
Ideggyógyászati szemle. 73:43-49
With improving treatment options, more attention is being paid to the neurocognitive symptoms related to hepatitis C infection (HCI). While HCI-related neurocognitive impairments are frequently subclinical, they can influence patients' quality of lif
Autor:
Klára Werling, Mihály Makara, Krisztina Nemesi, Gábor Horváth, Ferenc Schneider, Ildikó Bali, Judit Enyedi, Viktor Jancsik, András Káfony, Miklós Lesch, Béla Lombay, Zsófia Müller, Zsófia Ozsvár, Árpád Patai, Zoltán Péterfi, Margit Pusztay, Olga Szabó, János Szlávik, Tamás Tóth, Márta Varga, Judit Gács, Eszter Újhelyi, Anna Nemes Nagy
Publikováno v:
Orvosi hetilap. 163(22)
Bevezetés és célkitűzés: Az Európai Unióban a hepatitis C-vírussal (HCV) fertőzött betegek kétharmada nem tud a fertőzöttségéről. A WHO célja 2030-ra az új krónikus hepatitises esetek számának 90%-os csökkentése. A börtönökb
Autor:
Judit Gervain, László Rókusz, Klára Werling, Mihály Makara, Gábor V. Horváth, Gabriella Lengyel, Béla Hunyady, István Tornai, Alajos Pár, Ferenc Szalay, Zsuzsanna Gerlei
Publikováno v:
Central European Journal of Gastroenterology and Hepatology. 5:185-197
Autor:
Benjamin Maasoumy, Bela Hunyady, Vincenza Calvaruso, Mihály Makara, Johannes Vermehren, Attila Haragh, Simone Susser, Birgit Bremer, Gavin Cloherty, Michael P Manns, Antonio Craxì, Heiner Wedemeyer, Christoph Sarrazin
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e110857 (2014)
On-treatment HCV RNA measurements are crucial for the prediction of a sustained virological response (SVR) and to determine treatment futility during protease inhibitor-based triple therapies. In patients with advanced liver disease an accurate risk/
Externí odkaz:
https://doaj.org/article/9c48263b792c4e329d97dcc861cbdd68
Autor:
Pavel Drastich, Krasimir Antonov, Borut Štabuc, Željko Puljiz, Anca Trifan, M. V. Maevskaya, Robert Flisiak, Peter Jarcuska, Mihály Makara
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 5419, p 5419 (2021)
Journal of Clinical Medicine
Journal of Clinical Medicine
Background: Second-generation thrombopoietin receptor agonists (TPO-RAs) are emerging as the new standard for managing thrombocytopenia (TCP) in patients with chronic liver diseases (CLDs) undergoing scheduled procedures. However, practical guidance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406cec338228aa14259a7e5048b58311
https://doi.org/10.3390/jcm10225419
https://doi.org/10.3390/jcm10225419
Autor:
Zsuzsanna Gerlei, Béla Hunyady, Judit Gervain, Ferenc Szalay, Gábor Horváth, László Rókusz, Klára Werling, Mihály Makara, István Tornai, Alajos Pár, Gabriella Lengyel
Publikováno v:
Orvosi Hetilap. 159:24-37
Diagnosis and treatment of hepatitis B virus (HBV) and hepatitis D virus infection mean for the patient to be able to maintain working capacity, to increase quality of life, to prevent cancer, and to prolong life expectancy, while the society benefit
Autor:
Ferenc Schneider, Zsuzsanna Gerlei, Gabriella Lengyel, László Rókusz, Klára Werling, Béla Hunyady, Zoltán Péter, Gábor Horváth, István Tornai, Mihály Makara, Ferenc Szalay, Judit Gervain, Alajos Pár
Publikováno v:
Orvosi Hetilap. 158:3-22
Treatment of hepatitis C is based on a national consensus guideline updated six-monthly according to local availability and affordability of approved therapies through a transparent allocation system in Hungary. This updated guideline incorporates so